Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Capstone Therapeutics Corp. (CAPS) had Cash Flow from Investing Activities of $-0.03M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$12.64M |
|
$-1.92M |
|
$9.67M |
|
$2.97M |
|
$14.13M |
|
$-1.50M |
|
$-0.42M |
|
$-1.91M |
|
$-1.91M |
|
$-1.91M |
|
$-1.91M |
|
$-1.92M |
|
$-1.91M |
|
$-1.50M |
|
$-0.96M |
|
9.33M |
|
9.33M |
|
$-0.21 |
|
$-0.21 |
|
| Balance Sheet Financials | |
$25.98M |
|
$2.00M |
|
$27.82M |
|
$53.80M |
|
$27.43M |
|
$8.79M |
|
$15.15M |
|
$42.57M |
|
$11.19M |
|
$-9.05M |
|
$11.22M |
|
9.43M |
|
| Cash Flow Statement Financials | |
$-2.79M |
|
|
Cash Flow from Investing Activities |
$-0.03M |
$2.51M |
|
$0.73M |
|
$0.42M |
|
$-0.31M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.95 |
|
-- |
|
-- |
|
0.44 |
|
2.31 |
|
23.50% |
|
-11.85% |
|
-11.85% |
|
-- |
|
-15.14% |
|
-15.16% |
|
$-2.82M |
|
-- |
|
-- |
|
-- |
|
0.23 |
|
0.54 |
|
1.83 |
|
49.12 |
|
-17.07% |
|
21.13% |
|
-3.55% |
|
-9.55% |
|
$1.19 |
|
$-0.30 |
|
$-0.30 |
|